For: | Maher J. Role of the clinical immunology laboratory in disease monitoring. World J Immunol 2013; 3(2): 18-30 [DOI: 10.5411/wji.v3.i2.18] |
---|---|
URL: | https://www.wjgnet.com/2219-2824/full/v3/i2/18.htm |
Number | Citing Articles |
1 |
Nashwa T. Allam, Maha A. Ali, Doaa M. El-Abed, Abeer M. Zahran. Serum beta2-microglobulin level in systemic lupus erythematosus patients: Relation to disease activity. The Egyptian Rheumatologist 2023; 45(1): 55 doi: 10.1016/j.ejr.2022.10.002
|
2 |
R Hira-Kazal, P Shea-Simonds, J L Peacock, J Maher. How should a district general hospital immunology service screen for anti-nuclear antibodies? An ‘in-the-field’ audit. Clinical and Experimental Immunology 2015; 180(1): 52 doi: 10.1111/cei.12556
|
3 |
M H Hristova, V S Stoyanova. Autoantibodies against complement components in systemic lupus erythematosus – role in the pathogenesis and clinical manifestations. Lupus 2017; 26(14): 1550 doi: 10.1177/0961203317709347
|
4 |
Ivana Lapić, Dunja Rogić, Mirjana Fuček, Ružica Galović. Effectiveness of minimum retesting intervals in managing repetitive laboratory testing: experience from a Croatian university hospital. Biochemia medica 2019; 29(3): 531 doi: 10.11613/BM.2019.030705
|
5 |
Andrea Tešija Kuna, Lovorka Đerek, Vedrana Drvar, Ana Kozmar, Katarina Gugo. Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochemia medica 2021; 31(2): 210 doi: 10.11613/BM.2021.020502
|